Progress in One-pot Bioconversion of Cephalosporin C to 7-Aminocephalosporanic Acid.
Progress in One-pot Bioconversion of Cephalosporin C to 7-Aminocephalosporanic Acid.
复制标题
DOI:
10.2174/1389201019666180509093956
复制
发表时间:
2018-05
影响因子:
2.8
通讯作者:
Q. Tan;J. Qiu;Xiang Luo;Yewang Zhang;Yuting Liu;Yuquan Chen;Jing Yuan;W. Liao
中科院分区:
文献类型:
--
作者:
Q. Tan;J. Qiu;Xiang Luo;Yewang Zhang;Yuting Liu;Yuquan Chen;Jing Yuan;W. Liao
BACKGROUND Cephalosporins are the most widely used semisynthetic antibiotics, which acted on bacterial cell wall (peptidoglycan) synthesis. The key intermediate for fabricating about twothirds of cephalosporins in clinical use is 7-aminocephalosporanic acid (7-ACA), which is derived from chemical or enzymatic deacylation of the natural antibiotic cephalosporin C (CPC). The chemical deacylation process has been replaced by the enzymatic deacylation process because the chemical process required harsh conditions and released toxic waste. METHODS A two-step enzymatic process that utilized D-amino acid oxidase (DAAO) and 7-β-(4carboxybutanamido)-cephalosporanic acid acylase (GLA) for two successive reactions has been applied for the conversion of CPC to 7-ACA in an industrial scale. RESULTS To simplify the process and lower costs, the one-pot enzymatic processes were developed by the application of the mono-enzymatic process (application of cephalosporin C acylase or the variants of GLA), di-enzymatic process (simultaneous action of DAAO and GLA) or the tri-enzymatic process (simultaneous action of DAAO, GLA and catalase) for direct conversion of CPC to 7-ACA. CONCLUSION Here, we mainly focused on the description of these one-pot enzymatic processes and emphasized on the preparation of the involved biocatalysts.